13F
中

COLL COLLEGIUM PHARMACEUTICAL INC

2026Q1 · CUSIP 19459J104 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price
Holders
264
Δ holders QoQ
-13
Breadth percentile
Top 89%
Whale holders
134
Δ whales
-4
Inst. holding value
$1.2B
New positions
41
Closed positions
54
Price momentum (1Q)
-27.0%
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ+39 · h=140 2018Q2: Δ-5 · h=135 2018Q3: Δ-10 · h=125 2018Q4: Δ-4 · h=121 2019Q1: Δ+24 · h=145 2019Q2: Δ-19 · h=126 2019Q3: Δ-9 · h=117 2019Q4: Δ+20 · h=137 2020Q1: Δ+21 · h=158 2020Q2: Δ-7 · h=151 2020Q3: Δ-9 · h=142 2020Q4: Δ-3 · h=139 2021Q1: Δ+23 · h=162 2021Q2: Δ-3 · h=159 2021Q3: Δ-5 · h=154 2021Q4: Δ+7 · h=161 2022Q1: Δ+11 · h=172 2022Q2: Δ-13 · h=159 2022Q3: Δ+12 · h=171 2022Q4: Δ+9 · h=180 2023Q1: Δ+17 · h=197 2023Q2: Δ-17 · h=180 2023Q3: Δ-5 · h=175 2023Q4: Δ+19 · h=194 2024Q1: Δ+36 · h=230 2024Q2: Δ-1 · h=229 2024Q3: Δ+21 · h=250 2024Q4: Δ-11 · h=239 2025Q1: Δ+4 · h=243 2025Q2: Δ-18 · h=225 2025Q3: Δ+19 · h=244 2025Q4: Δ+33 · h=277 2026Q1: Δ-13 · h=264 2018Q1: holders=140 2018Q2: holders=135 2018Q3: holders=125 2018Q4: holders=121 2019Q1: holders=145 2019Q2: holders=126 2019Q3: holders=117 2019Q4: holders=137 2020Q1: holders=158 2020Q2: holders=151 2020Q3: holders=142 2020Q4: holders=139 2021Q1: holders=162 2021Q2: holders=159 2021Q3: holders=154 2021Q4: holders=161 2022Q1: holders=172 2022Q2: holders=159 2022Q3: holders=171 2022Q4: holders=180 2023Q1: holders=197 2023Q2: holders=180 2023Q3: holders=175 2023Q4: holders=194 2024Q1: holders=230 2024Q2: holders=229 2024Q3: holders=250 2024Q4: holders=239 2025Q1: holders=243 2025Q2: holders=225 2025Q3: holders=244 2025Q4: holders=277 2026Q1: holders=264 -39 -19.5 +0 +19.5 +39 105198291 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 11 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 16% -27.0% —
2025Q3 Top 17% -0.4% -24.5%
2024Q3 Top 16% -0.3% -1.4%
2024Q1 Top 7% +11.1% -8.9%
2023Q1 Top 9% +2.5% +9.3%
2022Q3 Top 11% +29.5% +10.9%
2022Q1 Top 17% +14.6% +37.0%
2021Q1 Top 15% -10.8% -14.5%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
17.0
EPS (TTM)
$2.04
EPS YoY
+67.2%
Revenue (TTM)
$0.8B
Revenue YoY
+19.9%
Quarterly Revenue & EPS (4Y)
2022-06-30: $124M 2022-09-30: $127M 2022-12-31: $130M 2023-03-31: $145M 2023-06-30: $136M 2023-09-30: $137M 2023-12-31: $150M 2024-03-31: $145M 2024-06-30: $145M 2024-09-30: $159M 2024-12-31: $182M 2025-03-31: $178M 2025-06-30: $188M 2025-09-30: $209M 2025-12-31: $205M 2026-03-31: $194M 2022-06-30: EPS -0.15 2022-09-30: EPS 0.01 2022-12-31: EPS -0.21 2023-03-31: EPS -0.51 2023-06-30: EPS 0.34 2023-09-30: EPS 0.53 2023-12-31: EPS 0.82 2024-03-31: EPS 0.71 2024-06-30: EPS 0.52 2024-09-30: EPS 0.27 2024-12-31: EPS 0.36 2025-03-31: EPS 0.07 2025-06-30: EPS 0.34 2025-09-30: EPS 0.84 2025-12-31: EPS 0.46 2026-03-31: EPS 0.40 0M 105M 209M $M -0.56 0.18 0.92 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 25 2023-09-30: PE 167.52023-12-31: PE 27.62024-03-31: PE 13.52024-06-30: PE 13.72024-09-30: PE 12.72024-12-31: PE 15.92025-03-31: PE 24.82025-06-30: PE 36.32025-09-30: PE 28.62025-12-31: PE 26.82026-03-31: PE 16.6 11 94 176 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)